A new meta-study — a study of studies — reveals an inconvenient truth about weight loss itself: Willpower still matters. Manufacturers of GLP-1 injectables like Wegovy and Ozempic would prefer we forget that, since forgetting it is profitable.
The counter-claim — that diets and exercise are no match for our genes and environment — is one fat-positivity influencers have pushed for years. Now it has been eagerly adopted by companies like Novo Nordisk and Eli Lilly to market their new, lizard-venom-derived blockbuster drugs.
People who stop taking weight-loss drugs regain weight at an average rate of 0.4 kilograms per month — roughly 10 pounds per year.
Business is booming. One in eight American adults have taken a weight-loss drug at one time — and this is only
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!